Motive Wealth Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
SC
ONB
GIM
WAM
CRM
Motive Wealth Advisors's LLY Position: Q2 2026 in Review
Motive Wealth Advisors increased its Eli Lilly (LLY) stake by 0.43% in Q2 2026, buying an estimated $4.09K and bringing the position to 934 shares worth $1.12M. The position accounts for 0.46% of the portfolio, ranked #35.
Motive Wealth Advisors first reported a position in LLY in Q3 2022 and has held it in 16 quarters since. 1,103 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Motive Wealth Advisors held 934 shares of Eli Lilly worth $1.12M as of Q2 2026.
- Motive Wealth Advisors bought 4 Eli Lilly shares in Q2 2026, an estimated $4.09K.
- Eli Lilly made up 0.46% of Motive Wealth Advisors's portfolio in Q2 2026, its #35 holding.
- Motive Wealth Advisors first reported a position in Eli Lilly in Q3 2022 and has held it in 16 quarters since.
- 1,103 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Motive Wealth Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.